|
ISIN No
|
INE901L01018
|
BSE Code / NSE Code
|
533573 / APLLTD
|
Book Value (Rs.)
|
297.45
|
Face Value
|
2.00
|
|
Bookclosure
|
29/07/2026
|
52Week High
|
998
|
EPS
|
34.33
|
P/E
|
23.75
|
|
Market Cap.
|
16024.81 Cr.
|
52Week Low
|
636
|
P/BV / Div Yield (%)
|
2.74 / 1.47
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
You can view the investment break up of the company with details such as Security name, Security type, Company type, investmement cost etc.
| YearEnd | Security Name | Security Type | Company Type | Cost of Investments |
| 2603 |
Alembic Pharmaceuticals Inc.
| Equity Share | Subsidiary | 122.36 |
| 2603 |
Leyden Laboratories B.V.
| Equity Share | Company | 57.67 |
| 2603 |
ABCD Technologies LLP
| Others | Partnership Firm | 33.93 |
| 2603 |
Alembic Global Holding SA
| Equity Share | Subsidiary | 30.31 |
| 2603 |
Investment in Alternative Investment Equity Fund
| Alternate Investment Fund | Others | 14.45 |
| 2603 |
Jamnagar Renewables One Pvt. Ltd.
| Equity Share | Company | 6.67 |
| 2603 |
Incozen Therapeutics Pvt. Ltd.
| Equity Share | Associate | 3.00 |
| 2603 |
Alembbic Pharmaceuticals Chile SpA
| Equity Share | Subsidiary | 2.40 |
|